-Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant in Major Depressive Disorder

Media coverage

• Title	-Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant in Major Depressive Disorder
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	19/07/23
  URL	ct.moreover.com/?a=51342215697&p=1gw&v=1&x=OYhQqOUsWeRv9UEPgwdwpw
  Persons	Sanjay Mathew

• Title	-Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant in Major Depressive Disorder
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	19/07/23
  URL	ct.moreover.com/?a=51342217855&p=1gw&v=1&x=AJ_0txJHWNWOnch6ZxIyEQ
  Persons	Sanjay Mathew